H.C. Wainwright 22nd Annual Global Investment Conference – Virtual Conference

GenSight Biologics draws down the €4 million second tranche of bonds from Kreos Capital

GenSight Biologics Reports Interim Financial Results for the First Half of 2020 and Provides Operational Update

GenSight Biologics obtains a €7m non-dilutive loan and renegotiates the bond agreement with Kreos Capital extending runway to mid-2021

GenSight Biologics Reports Cash Position as of March 31, 2020 and Provides Operational Update

H.C. Wainwright Global Life Sciences Conference, London, UK – cancelled

GenSight Biologics Provides Update on Operations in the Context of COVID-19

GenSight Biologics Reports Full Year 2019 Financial Results and provides an Outlook on 2020

GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update

GenSight Biologics Announces its 2020 Financial Calendar